^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
JNJ-9530
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
AbelZeta Pharma, J&J
Drug class:
CD20-targeted CAR-T immunotherapy
Related drugs:
